Page last updated: 2024-09-05

razaxaban and thiophenes

razaxaban has been researched along with thiophenes in 1 studies

Compound Research Comparison

Studies (razaxaban)	Trials (razaxaban)	Recent Studies (post-2010) (razaxaban)	Studies (thiophenes)	Trials (thiophenes)	Recent Studies (post-2010) (thiophenes)
20	0	2	17,012	1,961	8,038

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, YC; Frost, C; Shenker, A; Wang, Z	1

Other Studies

1 other study(ies) available for razaxaban and thiophenes

Article	Year
Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay. Thrombosis and haemostasis, 2010, Volume: 104, Issue:6 Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Humans; International Normalized Ratio; Isoxazoles; Morpholines; Predictive Value of Tests; Prothrombin Time; Pyrazoles; Pyridones; Reproducibility of Results; Rivaroxaban; Thiophenes; Venous Thromboembolism	2010

Article

Year

Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.

Thrombosis and haemostasis, 2010, Volume: 104, Issue:6

Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Humans; International Normalized Ratio; Isoxazoles; Morpholines; Predictive Value of Tests; Prothrombin Time; Pyrazoles; Pyridones; Reproducibility of Results; Rivaroxaban; Thiophenes; Venous Thromboembolism

2010